We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RNXT market cap is 24.48M. The company's latest EPS is USD -0.4263 and P/E is -2.39.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.98M | -1.78M | -2.48M | -3.03M | -2.83M |
| Net Income | -1.42M | -3.23M | -1.08M | -2.39M | -2.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.9M | -3.2M | -5.67M | -9.95M | -11.4M |
| Net Income | -3.84M | -3.8M | -6.32M | -9.89M | -10.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.52M | 1.47M | 4.79M | 12M | 10.03M |
| Total Liabilities | 3.51M | 4.47M | 3.02M | 2.73M | 2.96M |
| Total Equity | 6k | -3M | 1.77M | 9.27M | 7.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.27M | 1.91M | 16.29M | 7.27M | 1.47M |
| Total Liabilities | 805k | 4.12M | 938k | 1.1M | 4.47M |
| Total Equity | -10.93M | -14.66M | 15.35M | 6.16M | -3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.21M | -10.26M | -2.2M | -4.5M | -6.7M |
| Investing | 2.03M | 2.03M | N/A | N/A | N/A |
| Financing | 5.01M | 5.01M | 5.42M | 15.07M | 15.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.35M | -3.53M | -5.92M | -8.81M | -10.26M |
| Investing | -1,000 | N/A | -15k | -2.03M | 2.03M |
| Financing | N/A | 3.2M | 19.33M | 42k | 5.01M |
| Market Cap | 24.48M |
| Price to Earnings Ratio | -2.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 20.86 |
| Price to Book Ratio | -8.16 |
| Dividend Yield | - |
| Shares Outstanding | 24M |
| Average Volume (1 week) | 40.62k |
| Average Volume (1 Month) | 99.32k |
| 52 Week Change | -19.05% |
| 52 Week High | 1.6899 |
| 52 Week Low | 0.7736 |
| Spread (Intraday) | 0.12 (10.9%) |
| Company Name | RenovoRx Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.renovorx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
